Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Jan 31, 2005

30339_dirs_2005-01-31_d22f9e4f-279a-46fe-934b-6b1bb111f016.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-01-28

Reporting Person: ELLERS STEVEN A (Pres., Pharma. Systems Div.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-01-28 Common Stock A 14.2996 $25.8100 Acquired 11268.9934 Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 72885.6325 Direct
Common Stock 2758.7602 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.